Increased risk of high-grade prostate cancer among infertile men

Cancer

Volumn 116, Issue 9, 2010, Pages 2140-2147

  Walsh, Thomas J ^a,b   Schembri, Michael ^b   Turek, Paul J ^c   Chan, June M ^b,d   Carroll, Peter R ^b   Smith, James F ^b   Eisenberg, Michael L ^b   Van Den Eeden, Stephen K ^e   Croughan, Mary S ^b,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Turek Clinic   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DIVISION OF RESEARCH   (United States)

Author keywords

Incidence; Male infertility; Prostate cancer; Risk

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; DEMOGRAPHY; GLEASON SCORE; GROUPS BY AGE; HUMAN; MALE; MALE INFERTILITY; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR;

ADULT; HUMANS; INCIDENCE; INFERTILITY, MALE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK; SEMEN ANALYSIS;

EID: 77951436933     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25075     Document Type: Article

References (23)

1. Gronberg H. Prostate cancer epidemiology. Lancet. 2003;361:859-864.
2. Jorgensen KT, Pedersen BV, Johansen C, Frisch M. Fatherhood status and prostate cancer risk. Cancer. 2008;112:919-923. (Pubitemid 351240586)
3. Giwercman A, Richiardi L, Kaijser M, Ekbom A, Akre O. Reduced risk of prostate cancer in men who are childless as compared to those who have fathered a child: a population based case-control study. Int J Cancer. 2005;115:994-997. (Pubitemid 40791840)
4. Negri E, Talamini R, Bosetti C, Montella M, Franceschi S, La Vecchia C. Risk of prostate cancer in men who are childless. Int J Cancer. 2006;118:786-787; author reply 788.
5. Dennis LK, Dawson DV. Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology. 2002;13:72-79. (Pubitemid 34031513)
6. Walsh TJ, Croughan MS, Schembri M, Chan JM, Turek PJ. Increased risk of testicular germ cell cancer among infertile men. Arch Intern Med. 2009;169:351-356.
7. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 4th ed. Cambridge, UK: Cambridge University Press; 1999.
8. Roetzheim RG, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst. 1999;91:1409-1415. (Pubitemid 29400000)
9. Johansson JE, Andren O, Andersson SO, et al. Natural history of early, localized prostate cancer. JAMA. 2004;291:2713-2719. (Pubitemid 38725420)
10. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005;293:2095-2101. (Pubitemid 40617061)
11. Byar DP, Mostofi FK. Cancer of the prostate in men less than 50 years old: an analysis of 51 cases. J Urol. 1969;102:726-733.
12. Breslow N, Chan CW, Dhom G, et al. Latent carcinoma of prostate at autopsy in 7 areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer. 1977;20:680-688.
13. Rullis I, Shaeffer JA, Lilien OM. Incidence of prostatic carcinoma in the elderly. Urology. 1975;6:295-297.
14. Harlap S, Friedlander Y, Barchana M, et al. Late fetal death in offspring and subsequent incidence of prostate cancer in fathers: the Jerusalem Perinatal Study cohort. Prostate. 2007;67:989-998. (Pubitemid 46828932)
15. Harlap S, Paltiel O, Friedlander Y, et al. Prostate cancer in fathers with fewer male offspring: the Jerusalem Perinatal Study cohort. J Natl Cancer Inst. 2007;99:77-81.
16. Jain T, Gupta RS. Trends in the use of intracytoplasmic sperm injection in the United States. N Engl J Med. 2007;357:251-257. (Pubitemid 47080389)
17. Maduro MR, Casella R, Kim E, et al. Microsatellite instability and defects in mismatch repair proteins: a new aetiology for Sertoli cell-only syndrome. Mol Hum Reprod. 2003;9:61-68. (Pubitemid 36285145)
18. Nudell D, Castillo M, Turek PJ, Pera RR. Increased frequency of mutations in DNA from infertile men with meiotic arrest. Hum Reprod. 2000;15:1289-1294. (Pubitemid 30335952)
19. Baker SM, Plug AW, Prolla TA, et al. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet. 1996;13:336-342. (Pubitemid 26230500)
20. de Wind N, Dekker M, Berns A, Radman M, te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell. 1995;82:321-330.
21. Jass JR, Cottier DS, Jeevaratnam P, et al. Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Lancet. 1995;346:1200-1201.
22. Hirata H, Hinoda Y, Kawamoto K, et al. Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer. J Urol. 2008;179:2020-2024.
23. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science. 2005;308:1466-1469.